Clinical Trial Update: The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients

View source ↗

Summary

The trial update reports termination of a study examining the roles of visceral hyperalgesia, gastroesophageal reflux disease, and esophageal motility disorder …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Motility Disorders
• Gastroesophageal Reflux Disease
• Non-cardiac Chest Pain

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Non-Cardiac Chest Pain | Status: TERMINATED